Search - tctmd.com

Displaying 61 - 80 of 134

Sort: Relevancy | Date

News Conference News ACC 2020

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

Michael O'Riordan

April 06, 2020

News Conference News ACC 2020

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Michael O'Riordan

March 19, 2020

News Daily News

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

L.A. McKeown

March 16, 2020

News Daily News

Transradial Route Gains Support as Default for Secondary TAVR Access

Yael L. Maxwell

March 02, 2020

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

L.A. McKeown

February 27, 2020

News Conference News STS 2020

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

Yael L. Maxwell

February 07, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Todd Neale

January 29, 2020

News CV Team Pro

The Emory Healthcare Cath Lab Teams

L.A. McKeown

December 18, 2019

Presentation TCT Abstracts Posters 2019

In TAVI the less antibiotics, the better!

Presenter: Ioannis Iakovou

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

Presentation TVT 2019

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Presenter: Sarah Gualano

June 13, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Conference News STS 2019

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Yael L. Maxwell

January 30, 2019

Advertisement

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

Transradial Route Gains Support as Default for Secondary TAVR Access

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

ACS After TAVR a Unique Condition With Poor Prognosis

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

The Emory Healthcare Cath Lab Teams

In TAVI the less antibiotics, the better!

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Portico Noninferior to Commercial TAVR Valves in IDE Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content